VR Logo

Ajanta Pharma: Board Meeting Intimation for Quarterly Results And Consider Declaration Of Interim Dividend

AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 inter alia to consider and approve Pursuant to Regulation 29 of the Listing Regulations we hereby inform that a Meeting of the Board of Directors of the Company will be held on Tuesday 3rd November 2020 to inter-alia:

1. Approve and take on record unaudited consolidated & standalone Financial Results of the Company for the second quarter and half year ended 30th September 2020 and
2. Consider declaration of interim dividend.

You are requested to please take a note of the same and disseminate to all concerned.

Click here to view PDF